| (CAD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 14.67M | — |
| Operating expense | — | — |
| Net income | -1.02M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HLS.TO returned -29.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -23.4% |
| 1 year | -29.3% |
| 5 years | -79.5% |
| All-time high | $25.50 (Dec 2019) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in HLS.TO would be worth today ›No. HLS Therapeutics Inc. has not paid a dividend in the past 12 months.
HLS Therapeutics Inc. is part of the Healthcare sector.
HLS Therapeutics Inc. has a market cap of 114.15M CAD, based on the latest quote.
HLS Therapeutics Inc. is scheduled to report earnings on Nov 12, 2026.
